Terms: = Uterine cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Diagnosis
42 results:
1. Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.
Lee Y; Choi S; Kim HS
Int J Gynecol Pathol; 2024 May; 43(3):221-232. PubMed ID: 37566876
[TBL] [Abstract] [Full Text] [Related]
2. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
3. [A Case of De Novo Stage Ⅳ Breast cancer with Umbilical Metastasis and Peritoneal Dissemination].
Mitsuyoshi A; Yanagawa T; Kikumori K; Hori A; Oshima K; Shinke G; Katsuyama S; Ikeshima R; Hiraki M; Ohmura Y; Sugimura K; Masuzawa T; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2023 Mar; 50(3):366-368. PubMed ID: 36927911
[TBL] [Abstract] [Full Text] [Related]
4. Metastasis of endometrial cancer to breast: A rare case.
Erdoğan Ö; Balci MF; Özgüzer A; Özdaş E; Görgülü G; Sanci M
J Obstet Gynaecol Res; 2023 May; 49(5):1452-1455. PubMed ID: 36828642
[TBL] [Abstract] [Full Text] [Related]
5. An unusual case of carcinoma with mesonephric-like features with a spindle cell component diagnosed on the Pap test of the uterine cervix: Cytomorphologic and immunophenotypic features and diagnostic pitfalls.
Besharati S; Liu-Jarin X; Chen X; Cimic A
Diagn Cytopathol; 2022 Nov; 50(11):E325-E329. PubMed ID: 35778908
[TBL] [Abstract] [Full Text] [Related]
6. TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review.
Purwar R; Soni K; Shukla M; Verma A; Kumar T; Pandey M
World J Surg Oncol; 2022 Mar; 20(1):62. PubMed ID: 35232443
[TBL] [Abstract] [Full Text] [Related]
7. Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive Entity.
Mills AM; Jenkins TM; Howitt BE; Fan J; Ring KL; Cook I
Am J Surg Pathol; 2022 Jul; 46(7):921-932. PubMed ID: 35195579
[TBL] [Abstract] [Full Text] [Related]
8. Can we reduce dose to ureters as avoidance organs for MRI based brachytherapy for cervical cancer? A dosimetric feasibility study.
Koerner SA; Baig T; Kim H; Rodríguez-López J; Keller A; Beriwal S
Brachytherapy; 2022; 21(2):202-207. PubMed ID: 34980569
[TBL] [Abstract] [Full Text] [Related]
9. Testing Algorithms for the diagnosis of Malignant Glandular Tumors of the uterine Cervix Histotyped per the International Endocervical Adenocarcinoma Criteria and Classification (IECC) System.
Duggan MA; Duan Q; Pfeiffer RM; Brett MA; Lee S; Abubakar M; Köbel M; Rodriguez M; Sar A
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):91-98. PubMed ID: 34799503
[TBL] [Abstract] [Full Text] [Related]
10. Five-fraction hdr brachytherapy in locally advanced cervical cancer: A monocentric experience.
Ogorodniitchouk O; Aunier J; Bousarsar A; Lahmamssi C; Sotton S; Ouaz H; Moreno-Acosta P; Moslemi D; Molekzadehmoghani M; Langrand-Escure J; Magne N; Vallard A
Cancer Radiother; 2021 Jul; 25(5):463-468. PubMed ID: 34023215
[TBL] [Abstract] [Full Text] [Related]
11. Endometrial Mesonephric-like Adenocarcinoma Presenting as an Ocular Lesion: A Case Report.
Al Nabhani S; Doyle A; Kennedy S; McVey R; Crown J; Gibbons D
Int J Gynecol Pathol; 2022 Mar; 41(2):161-167. PubMed ID: 33935158
[TBL] [Abstract] [Full Text] [Related]
12. Prognosis of the patients suffered from uterine carcinosarcoma from rural and urban areas.
Danska-Bidzinska A; Nasierowska-Guttmejer A; Bakula-Zalewska E; Bidzinski M; Wierzba W
Ginekol Pol; 2021; 92(11):774-777. PubMed ID: 33914324
[TBL] [Abstract] [Full Text] [Related]
13. A case report of a patient with bulky uterine cervical neoplasm who achieved complete response with "intentional internal high-dose policy" high-dose-rate interstitial brachytherapy.
Kashihara T; Kobayashi K; Iijima K; Murakami N; Yoshida K; Okuma K; Nakamura S; Takahashi K; Inaba K; Igaki H; Nakayama Y; Kato T; Uno T; Itami J
Medicine (Baltimore); 2020 Jul; 99(27):e20860. PubMed ID: 32629674
[TBL] [Abstract] [Full Text] [Related]
14. Extraovarian Brenner tumor in the uterus: a case report and review of literature.
Hu RY; Deng YJ; Zhu HH; Zhou J; Hu M; Liang XQ; Xiao QJ; Zhou L; Peng XY; Zhang XW; Ji N; Deng H
Diagn Pathol; 2020 Mar; 15(1):22. PubMed ID: 32164751
[TBL] [Abstract] [Full Text] [Related]
15. Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior.
Euscher ED; Bassett R; Duose DY; Lan C; Wistuba I; Ramondetta L; Ramalingam P; Malpica A
Am J Surg Pathol; 2020 Apr; 44(4):429-443. PubMed ID: 31725471
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
[TBL] [Abstract] [Full Text] [Related]
17. Müllerian Adenosarcoma of the Urinary Bladder: Clinicopathologic and Immunohistochemical Features With Novel Genetic Aberrations.
Sanfrancesco J; Williamson SR; Kum JB; Zhang S; Wang M; Lopez-Beltran A; Montironi R; Gardner TA; Cheng L
Clin Genitourin Cancer; 2017 Dec; 15(6):e1007-e1014. PubMed ID: 28690098
[TBL] [Abstract] [Full Text] [Related]
18. [Application of immunohistochemistry for p16 and gata3 and molecular HPV typing in diagnosis of secondary bladder involvement by cervical carcinoma].
Huang RF; He C; Zhu WF; Li Y; Chen G
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):388-392. PubMed ID: 28591985
[No Abstract] [Full Text] [Related]
19. Haemoglobin monitoring in endometrial cancer patients undergoing radiotherapy.
Biete A; Holub K
Clin Transl Oncol; 2017 Dec; 19(12):1518-1523. PubMed ID: 28577151
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.
Kamran SC; Manuel MM; Cho LP; Damato AL; Schmidt EJ; Tempany C; Cormack RA; Viswanathan AN
Gynecol Oncol; 2017 May; 145(2):284-290. PubMed ID: 28318644
[TBL] [Abstract] [Full Text] [Related]
[Next]
